We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
+3.67%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$2.47B
AUM Growth
-$8.91M
Cap. Flow
-$61.4M
Cap. Flow %
-2.48%
Top 10 Hldgs %
64.01%
Holding
148
New
9
Increased
30
Reduced
67
Closed
14

Sector Composition

Rank Sector Weight
1 Technology 23.38%
2 Consumer Discretionary 15.08%
3 Energy 14.69%
4 Industrials 13.22%
5 Financials 12.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COGT icon
76
Cogent Biosciences
COGT
$7.24B
$1.33M 0.05%
157,851
-28,403
-15% -$215K
AURA icon
77
Aura Biosciences
AURA
$826M
$1.23M 0.05%
162,358
-17,787
-10% -$130K
RYAAY icon
78
Ryanair
RYAAY
$31.3B
$1.16M 0.05%
25,000
AMD icon
79
Advanced Micro Devices
AMD
$789B
$1.12M 0.05%
6,911
-1,321
-16% -$213K
ALLK
80
DELISTED
Allakos
ALLK
$1.06M 0.04%
1,060,139
-111,922
-10% -$133K
NICE icon
81
Nice
NICE
$5.97B
$952K 0.04%
+5,533
New +$1.14M
KROS icon
82
Keros Therapeutics
KROS
$221M
$927K 0.04%
20,293
-14,422
-42% -$775K
KURA icon
83
Kura Oncology
KURA
$850M
$862K 0.03%
41,874
-4,915
-11% -$101K
CYTK icon
84
Cytokinetics
CYTK
$10.4B
$784K 0.03%
14,478
-1,648
-10% -$99.5K
FDMT icon
85
4D Molecular Therapeutics
FDMT
$562M
$768K 0.03%
36,572
-4,195
-10% -$105K
TKNO icon
86
Alpha Teknova
TKNO
$347M
$728K 0.03%
531,414
-196,347
-27% -$374K
OMGA
87
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$717K 0.03%
346,352
-540,430
-61% -$1.27M
CDXS icon
88
Codexis
CDXS
$158M
$620K 0.03%
200,063
-29,604
-13% -$95.1K
CDNS icon
89
Cadence Design Systems
CDNS
$93.4B
$596K 0.02%
1,938
+130
+7% +$38.5K
FIVN icon
90
FIVE9
FIVN
$2.54B
$445K 0.02%
+10,087
New +$524K
BALL icon
91
Ball Corp
BALL
$16.8B
$390K 0.02%
6,505
-551,835
-99% -$37M
MTAL
92
DELISTED
Metals Acquisition
MTAL
$355K 0.01%
25,902
-1,871,121
-99% -$25.3M
SUZ icon
93
Suzano
SUZ
$10.1B
$345K 0.01%
33,633
+4,314
+15% +$45.4K
APD icon
94
Air Products & Chemicals
APD
$67.6B
$328K 0.01%
1,273
INTC icon
95
Intel
INTC
$513B
$319K 0.01%
10,292
+3,722
+57% +$122K
NVDA icon
96
NVIDIA
NVDA
$5.42T
$300K 0.01%
2,431
-879
-27% -$88.9K
CCK icon
97
Crown Holdings
CCK
$13.1B
$298K 0.01%
4,003
CNM icon
98
Core & Main
CNM
$8.71B
$267K 0.01%
5,453
-1,631
-23% -$90.6K
AMBP icon
99
Ardagh Metal Packaging
AMBP
$3.01B
$228K 0.01%
66,982
ATKR icon
100
Atkore
ATKR
$3.16B
$215K 0.01%
1,594

Similar funds

Platinum Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Platinum Investment Management held 148 positions worth $2.47B, down 0.36% from $2.48B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Platinum Investment Management's Q2 2024 filing shows 9 new, 30 increased, 67 reduced and 14 closed positions. Its largest new stake was Lamb Weston: 729,393 shares worth $61.3M. The largest sale was Meta Platforms (Facebook), an estimated $48.7M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Energy.

  • Platinum Investment Management's largest Q2 2024 buy was Lamb Weston: 729,393 shares worth $61.3M.
  • Platinum Investment Management added most to Alphabet (Google) Class A in Q2 2024, an estimated $125M increase.
  • Platinum Investment Management's biggest Q2 2024 reduction was Meta Platforms (Facebook), cutting an estimated $48.7M.
  • Platinum Investment Management fully exited Inhibrx, Inc. Common Stock in Q2 2024, selling an estimated $5.1M.
  • Platinum Investment Management's ten largest holdings make up 64% of its $2.47B portfolio in Q2 2024.
  • Platinum Investment Management opened 9 new positions and closed 14 in Q2 2024.
  • Platinum Investment Management's portfolio value fell 0.36% quarter-over-quarter to $2.47B.

Based on Platinum Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.